Cargando…
Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911634/ https://www.ncbi.nlm.nih.gov/pubmed/36759503 http://dx.doi.org/10.1038/s41392-022-01262-x |
_version_ | 1784885029577424896 |
---|---|
author | Zhang, Linmeng Tang, Ning Yang, Chen Geng, Haigang Hang, Hualian Qin, Wenxin Wang, Cun |
author_facet | Zhang, Linmeng Tang, Ning Yang, Chen Geng, Haigang Hang, Hualian Qin, Wenxin Wang, Cun |
author_sort | Zhang, Linmeng |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9911634 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-99116342023-02-11 Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma Zhang, Linmeng Tang, Ning Yang, Chen Geng, Haigang Hang, Hualian Qin, Wenxin Wang, Cun Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-02-10 /pmc/articles/PMC9911634/ /pubmed/36759503 http://dx.doi.org/10.1038/s41392-022-01262-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter Zhang, Linmeng Tang, Ning Yang, Chen Geng, Haigang Hang, Hualian Qin, Wenxin Wang, Cun Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma |
title | Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma |
title_full | Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma |
title_fullStr | Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma |
title_full_unstemmed | Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma |
title_short | Combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma |
title_sort | combating inconsistent evaluation of intra-tumor immune status by a novel transcriptomic signature in hepatocellular carcinoma |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911634/ https://www.ncbi.nlm.nih.gov/pubmed/36759503 http://dx.doi.org/10.1038/s41392-022-01262-x |
work_keys_str_mv | AT zhanglinmeng combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma AT tangning combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma AT yangchen combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma AT genghaigang combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma AT hanghualian combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma AT qinwenxin combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma AT wangcun combatinginconsistentevaluationofintratumorimmunestatusbyanoveltranscriptomicsignatureinhepatocellularcarcinoma |